Review: Aspirin reduces CAD events in persons with no history of cardiovascular disease, but it increases gastrointestinal bleeding
- Daily aspirin: Underused therapy. // Consumer Reports on Health;Jul2000, Vol. 12 Issue 7, p7
Reports that a study by the American Heart Association has found that only 26 percent of people who had coronary heart disease and could have benefited from aspirin therapy were actually using it.
- Not enough people taking aspirin for heart benefits. // Mayo Clinic Health Letter;Feb1998, Vol. 16 Issue 2, p4
Focuses on the benefits of taking aspirin to prevent heart attacks. Reference to a report by the American Heart Association; Recommendations for daily intake of aspirins; Risk associated with large doses.
- Safer non-cardiac surgery for patients with coronary artery disease. Sonksen, Julian; Gray, Richard; Hutton Hickman, Peter // BMJ: British Medical Journal (International Edition);11/21/98, Vol. 317 Issue 7170, p1400
Editorial. Discusses the effect of non-cardiac surgery on patients with coronary artery disease. Why the role of percutaneous transluminal coronary angioplasty is less well defined; Role of Aspirin in the prevention of myocardial infarction; Most important determinants of cardiovascular stability.
- Aspirin backed for CHD primary prevention. // Pulse;2/23/2011, Vol. 71 Issue 7, p8
The article mentions the advantages of using aspirin as a treatment for primary prevention of coronary heart disease (CHD) than no treatment in middle-aged men with a greater than 10 percent 10-year risk of disease.
- Aspirin therapy: Low dose may not be enough. D'Epiro, Nancy Walsh // Patient Care;4/15/1998, Vol. 32 Issue 7, p26
Reports that according to a study from Cornell University Medical College in New York and University Hospital La Fe, Valencia, Spain, regular low dose aspirin may not be enough to prevent heart attacks and strokes in patients at risk for coronary disease. Advantage of low-dose aspirin; Comments...
- Aspirin and coronary artery disease. Da Rosa, Eduardo M.; Tormen, William C.; Lopes, Edna F.; Grove, Erik Lerkevang; W., Morten; Gislason, Gunnar Hilmar; Kristensen, Steen Dalby; Hvas, Anne-Mette // Heart;Oct2010, Vol. 96 Issue 20, p1684
A letter to the editor is presented in response to the article "Aspirin and coronary artery disease," by Erik Lerkevang Grove et al.
- Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Steg, P.G.; Lung, B.; Feldman, L.J.; Cokkinos, D.; Deckers, J.; Fox, K.A.A.; Keil, U.; Maggioni, A.P. // Heart;Jul2002, Vol. 88 Issue 1, p20
Background: It has been suggested that patients undergoing acute intervention for coronary syndromes may not receive adequate secondary prevention. Objective: To analyse the impact of availability and use of coronary interventions on the prescription of secondary prevention after acute coronary...
- Stopping aspirin raises CVD mortality risk. // Pulse;8/10/2011, Vol. 71 Issue 26, p8
The article reports that Spanish researchers have found that cessation of aspirin use as secondary prevention for cardiovascular disease can increase the risk of heart attack or coronary heart disease by 50%.
- Aspirin benefits patients with stroke--but only just. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1646
Discusses the therapeutic benefits that stroke patients derive from aspirin. Drop in recurrent ischemic strokes among patients administered heparin; Bias against heparin in the international stroke trial.